Moderna, facing high expectations and fierce competition, won’t meet Wall Street’s COVID estimates: analyst esagonowsky Tue, 09/08/2020 – […]

Mylan boosts Euro portfolio with $756M rights deal for Aspen’s injectable thrombosis meds kblankenship Tue, 09/08/2020 – 11:08

A phase three global clinical trial has shown that the drug vosoritide restores close-to-average bone growth rates of […]

Researchers developed a new class of medical instruments equipped with an advanced soft electronics system that could dramatically […]

Hundreds of innovators, research pioneers, clinicians, industry leaders and policy makers from all around Europe are united by […]

Leeds GP Mo Sattar was already involved in discussions about ethnic minority issues through the Royal College of […]

Preliminary guidelines reject NHS funding for the drug for BRAF V600E mutation-positive metastatic colorectal cancer

Inhaled ensifentrine will be assessed in hospitalised patients

The decisions bring a raft of new treatment options for conditions including epilepsy, depression and cancer

Treatment naïve patients lived longer without disease progression with the Imbruvica-based regimen than those given a chemotherapy-based one